CO 009: A NOVEL PEPTIDE SELECTED FROM AN ALASCANNING REGULATES THE ONCOGENIC ACTIVITY OF NFKB IN CANCER CELLS

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S5, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 009: A NOVEL PEPTIDE SELECTED FROM AN ALASCANNING REGULATES THE ONCOGENIC ACTIVITY OF NFKB IN CANCER CELLS Oliva B, Fernandez Jr, Gil J, Garay H, Reyes O, Guillen G, Vallespi GM. Center for Genetic Engineering … Continue reading CO 009: A NOVEL PEPTIDE SELECTED FROM AN ALASCANNING REGULATES THE ONCOGENIC ACTIVITY OF NFKB IN CANCER CELLS

J Pharm Pharmacogn Res 2(Suppl. 1): S5, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 009: A NOVEL PEPTIDE SELECTED FROM AN ALASCANNING REGULATES THE ONCOGENIC ACTIVITY OF NFKB IN CANCER CELLS

Oliva B, Fernandez Jr, Gil J, Garay H, Reyes O, Guillen G, Vallespi GM.

Center for Genetic Engineering and Biotechnology (CIGB), P.O.Box. 6162, Cubanacan, Playa, La Habana, Cuba.
Abstract

Introduction: The nuclear factor NFkB plays a critical role in diverse cellular processes associated with proliferation, cell death, as well as inflammation. Starting from a LPS-binding peptide from Limulus antiLPS factor, with powerful immunostimulatory activity, we have done alanine substitutions of particular residues and obtained a novel synthetic peptide (CIGB-552) that has lost its LPS binding capacity and is a powerful in vitro and in vivo cytotoxic agent. The potential mechanism responsible for the antitumor activity of CIGB-552 is based on a specific degradation of RelA (p65) and inhibition of NFkB regulated genes.

Material and methods: Cell lines: HT-29 (human colon cancer) and D122 (Lewis lung carcinoma). Female Balb/c mice were purchased from CENPALAB, Cuba. The peptide was synthesized manually using Fmoc/tBu solid phase.

Results: Here we demonstrate that treatment of tumor cells with the peptide CIGB-552 promotes the degradation of RelA (p65) and induces cell cycle arrest and apoptosis. In addition, the peptide inhibits gene products activated by NFkB, such as the anti-apoptotic protein Bcl-2. Here, we demonstrate that the CIGB-552 stabilizes a key protein in tumor cells, it which inhibits the transcription activity of NFkB. These findings provide evidence to support the regulation of transcription factor NFkB by the peptide CIGB- 552 in cancer cells. Furthermore, we demonstrate that CIGB-552 decrease tumor growth and increase survival in the human colon cancer xenograft HT-29 and shows anti-metastatic activity in a spontaneous metastatic model of the Lewis lung carcinoma.

Conclusion: Our finding points out to a novel mechanism by which the anti-apoptotic activity of NFkB can be regulated in cancer cells. Better understanding of the regulation of NFkB will provide a platform for development of specific therapeutic agents targeted towards the cancer-associated inflammation.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio